-

CELH SHAREHOLDER NEWS: Robbins LLP Reminds Shareholders of Class Action Against Celsius Holdings, Inc. (CELH)

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Celsius Holdings, Inc. (NASDAQ: CELH) securities between August 12, 2021 and March 1, 2022, for violations of the Securities Exchange Act of 1934. Celsius develops, markets, and sells functional drinks and liquid supplements.

If you would like more information about Celsius Holdings, Inc.'s misconduct, click here.

What is this Case About: Celsius Holdings, Inc. (CELH) Must Restate its Financial Statements

According to the complaint, on March 1, 2022, Celsius disclosed it could not timely file its 2021 annual report due to "staffing limitations, unanticipated delays and unidentified material errors in previous filings." Specifically, Celsius “determined that the calculation and expense of non-cash share-based compensation, related to grants of stock options and restricted stock units awarded to certain former employees and retired directors were materially understated for the three and six month periods ended June 30, 2021 and three and nine month periods ended September 30, 2021.” As a result, management concluded that there was a material weakness in the Company’s internal controls over financial reporting. On this news, the Company's stock fell to an intra-day low of $56.21 per share on March 2, 2022. Over two trading sessions, the Company's stock fell $5.20, or 8.3%, to close at $57.60 per share on March 3, 2022.

During the class period, defendants failed to disclose to investors that there was a material weakness in Celsius's internal controls over financial reporting, which caused the Company to improperly record expenses for non-cash share-based compensation for second and third quarters of 2021. As a result, the Company's financial statements for those periods would be restated, including to report a net loss for the third quarter of 2021.

Next Steps: Next Steps: If you acquired shares of Celsius Holdings, Inc. (CELH) between August 12, 2021 and March 1, 2022, you have until May 16, 2022, to ask the court to appoint you lead plaintiff for the class.

A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Celsuis Holdings, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:CELH

Release Summary
Celsius Holdings, Inc. (CELH) Must Restate its Financial Statements
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the SES AI Corporation Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired SES AI Corporation (NYSE: SES) securities between January 29, 2025 and March 4, 2026. SES claims to be a "leading developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (“Li-Metal”) and Lithium-ion (“Li-ion”) rechargeable battery technologies and battery materials for Energy Storage Systems (“ESS”), Urban Air Mobility (“UAM”)...

Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

Investor Notice: Robbins LLP Informs Investors of the Globant S.A. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Globant S.A. (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025. Globant is a Luxembourg-incorporated international technology company that provides digital consulting and related services. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LL...
Back to Newsroom